LFCR
NASDAQ · Life Sciences Tools & Services
Lifecore Biomedical Inc
$6.54
+0.01 (+0.15%)
Financial Highlights (FY 2026)
Revenue
75.97M
Net Income
-18,065,739
Gross Margin
31.4%
Profit Margin
-23.8%
Rev Growth
-9.9%
D/E Ratio
4.18
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 31.4% | 31.4% | 44.5% | 44.5% |
| Operating Margin | -1.0% | -0.9% | 6.5% | 6.6% |
| Profit Margin | -23.8% | -22.6% | 5.3% | 5.4% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 75.97M | 84.32M | 344.67M | 265.26M |
| Gross Profit | 23.83M | 26.45M | 153.43M | 118.09M |
| Operating Income | -736,866 | -736,129 | 22.32M | 17.47M |
| Net Income | -18,065,739 | -18,047,691 | 18.11M | 14.22M |
| Gross Margin | 31.4% | 31.4% | 44.5% | 44.5% |
| Operating Margin | -1.0% | -0.9% | 6.5% | 6.6% |
| Profit Margin | -23.8% | -22.6% | 5.3% | 5.4% |
| Rev Growth | -9.9% | -9.9% | +6.7% | +0.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 100.08M | 100.08M | 31.30M | 33.69M |
| Total Equity | 23.97M | 23.97M | 172.81M | 150.13M |
| D/E Ratio | 4.18 | 4.18 | 0.18 | 0.22 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 4.84M | 5.10M | 26.32M | 22.29M |
| Free Cash Flow | — | — | 8.29M | 10.33M |